Condition 1: Acute myeloblastic leukemia. Condition 2: Acute lymphoblastic leukemia [ALL]. Acute myeloblastic leukemia Acute lymphoblastic leukemia [ALL]
Conditions
Interventions
Intervention 1: Control group: The control group receives the hospital's usual care (including periodic physician visits and access to common educational pamphlets). Intervention 2: Intervention group
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Willingness to participate in the study and provision of written informed consent. Age of at least 18 years. No history of other malignancies. No prior participation in a continuous care model program. Ability to read and write in Persian. Ownership of a smartphone and ability to use the mobile application. No cognitive, hearing, or visual impairments based on the patient’s medical records. Access to the internet and basic digital literacy required to use the mobile application. At least three months have elapsed since the definitive diagnosis of acute leukemia by a specialist physician.
Exclusion criteria
Exclusion criteria: Death of the participant. Participant’s unwillingness to continue participation in the study. Failure to complete the questionnaires at any of the three assessment time points (before the intervention, immediately after the intervention, and two months after the intervention). Withdrawal from the care program during the study due to non-adherence to the intervention, defined as using the application fewer than two times per week.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean total score of patients on the Connor-Davidson Resilience Scale (CD-RISC). Timepoint: The questionnaire will be completed at three time points: at the beginning of the study (before the start of the intervention), at the end of the eighth week (immediately after the completion of the intervention period), and eight weeks after the end of the intervention. Method of measurement: Connor-Davidson Resilience Scale - 25 Item.;The mean total score of patients on the Self-Compassion Scale – Short Form (SCS–SF). Timepoint: The questionnaire will be completed at three time points: at the beginning of the study (before the start of the intervention), at the end of the eighth week (immediately after the completion of the intervention period), and eight weeks after the end of the intervention. Method of measurement: Self-Compassion Scale – Short Form , 12-item version. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSogand Soleimaninejadian
Shahre-kord University of Medical Sciences
Outcome results
None listed